Literature DB >> 17498801

Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.

Anne-Laure Goenaga1, Yu Zhou, Christine Legay, Houcine Bougherara, Lan Huang, Bin Liu, Daryl C Drummond, Dmitri B Kirpotin, Christian Auclair, James D Marks, Marie-Alix Poul.   

Abstract

To generate a panel of antibodies binding human breast cancers, a human single chain Fv phage display library was selected for rapid internalization into the SK-BR-3 breast cancer cell line. Thirteen unique antibodies were identified within the 55 cell binding antibodies studied, all of them showing specific staining of tumor cells compare to normal epithelial cells. Two of the antibodies bound the ErbB2 oncogene while 6 bound the tumor marker transferrin receptor (TfR). By developing a scFv immunoprecipitation method, we were able to use LC-MS/MS to identify the antigen bound by one of the antibodies (3GA5) as FPRP (prostaglandin F2alpha receptor-regulatory protein)/EWI-F/CD9P-1 (CD9 partner 1) an Ig superfamily member that has been described to interact directly with CD9 and CD81 tetraspanins and to be overexpressed in adherent cancer cell lines. Although the 3GA5 scFv had no direct anti-proliferative effect, intracellular expression of the scFv was able to knockdown CD9P-1 expression and could be used to further define the role of the tetraspanin system in proliferation and metastasis. Moreover, the 3GA5 scFv was rapidly internalized into breast tumor cells and could have potential for the targeted delivery of cytotoxic agents to breast cancers. This study is the proof of principle that the direct selection of phage antibody libraries on tumor cells can effectively lead to the identification and functional characterization of relevant tumor markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498801      PMCID: PMC2739904          DOI: 10.1016/j.molimm.2007.03.023

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  53 in total

1.  The major CD9 and CD81 molecular partner. Identification and characterization of the complexes.

Authors:  S Charrin; F Le Naour; M Oualid; M Billard; G Faure; S M Hanash; C Boucheix; E Rubinstein
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

Review 2.  Functional domains in tetraspanin proteins.

Authors:  Christopher S Stipp; Tatiana V Kolesnikova; Martin E Hemler
Journal:  Trends Biochem Sci       Date:  2003-02       Impact factor: 13.807

Review 3.  Arming antibodies: prospects and challenges for immunoconjugates.

Authors:  Anna M Wu; Peter D Senter
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

4.  Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting.

Authors:  Christine Mazuet; Dimitri Lerouge; Marie-Alix Poul; Nathalie Blin
Journal:  Biochem Biophys Res Commun       Date:  2006-07-28       Impact factor: 3.575

5.  In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.

Authors:  R Schier; J D Marks; E J Wolf; G Apell; C Wong; J E McCartney; M A Bookman; J S Huston; L L Houston; L M Weiner
Journal:  Immunotechnology       Date:  1995-05

6.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines.

Authors:  A J Hackett; H S Smith; E L Springer; R B Owens; W A Nelson-Rees; J L Riggs; M B Gardner
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

7.  Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.

Authors:  Gregory P Adams; Mei-Sheng Tai; John E McCartney; James D Marks; Walter F Stafford; L L Houston; James S Huston; Louis M Weiner
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

8.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

Review 9.  Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor.

Authors:  A Dautry-Varsat
Journal:  Biochimie       Date:  1986-03       Impact factor: 4.079

10.  Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

Authors:  J Baselga; L Norton; J Albanell; Y M Kim; J Mendelsohn
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

View more
  21 in total

Review 1.  Selection and characterization of cell binding and internalizing phage antibodies.

Authors:  Yu Zhou; Lequn Zhao; James D Marks
Journal:  Arch Biochem Biophys       Date:  2012-05-22       Impact factor: 4.013

2.  Discovery of internalizing antibodies to basal breast cancer cells.

Authors:  Yu Zhou; Hao Zou; Christina Yau; Lequn Zhao; Steven C Hall; Daryl C Drummond; Shauna Farr-Jones; John W Park; Christopher C Benz; James D Marks
Journal:  Protein Eng Des Sel       Date:  2018-01-01       Impact factor: 1.650

Review 3.  Selection strategies for anticancer antibody discovery: searching off the beaten path.

Authors:  David Sánchez-Martín; Morten Dræby Sørensen; Simon Lykkemark; Laura Sanz; Peter Kristensen; Erkki Ruoslahti; Luis Álvarez-Vallina
Journal:  Trends Biotechnol       Date:  2015-03-26       Impact factor: 19.536

4.  Discovery of internalizing antibodies to tumor antigens from phage libraries.

Authors:  Yu Zhou; James D Marks
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  Identification of tubby and tubby-like protein 1 as eat-me signals by phage display.

Authors:  Nora B Caberoy; Dony Maiguel; Youngbae Kim; Wei Li
Journal:  Exp Cell Res       Date:  2009-10-22       Impact factor: 3.905

6.  Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion.

Authors:  Fraser Conrad; Xiaodong Zhu; Xin Zhang; Robert J Chalkley; Alma L Burlingame; James D Marks; Bin Liu
Journal:  J Mol Med (Berl)       Date:  2009-02-14       Impact factor: 4.599

Review 7.  New perspective for phage display as an efficient and versatile technology of functional proteomics.

Authors:  Wei Li; Nora B Caberoy
Journal:  Appl Microbiol Biotechnol       Date:  2009-10-14       Impact factor: 4.813

8.  Can phage display be used as a tool to functionally identify endogenous eat-me signals in phagocytosis?

Authors:  Nora B Caberoy; Yixiong Zhou; Wei Li
Journal:  J Biomol Screen       Date:  2009-06-16

9.  Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic.

Authors:  Gene Kurosawa; Yasushi Akahori; Miwa Morita; Mariko Sumitomo; Noriko Sato; Chiho Muramatsu; Keiko Eguchi; Kazuki Matsuda; Akihiko Takasaki; Miho Tanaka; Yoshitaka Iba; Susumu Hamada-Tsutsumi; Yoshinori Ukai; Mamoru Shiraishi; Kazuhiro Suzuki; Maiko Kurosawa; Sally Fujiyama; Nobuhiro Takahashi; Ryoichi Kato; Yoshikazu Mizoguchi; Mikihiro Shamoto; Hiroyuki Tsuda; Mototaka Sugiura; Yoshinobu Hattori; Shuichi Miyakawa; Ryoichi Shiroki; Kiyotaka Hoshinaga; Nobuhiro Hayashi; Atsushi Sugioka; Yoshikazu Kurosawa
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

10.  Comprehensive Identification of Tumor-associated Antigens via Isolation of Human Monoclonal Antibodies that may be Therapeutic.

Authors:  Yoshikazu Kurosawa
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.